UTILITY Therapeutics Announces Capital Raise and 2021 Corporate Objectives
Financing from new and existing investors to advance two European-approved antibiotics for the U.S. market Pivmecillinam Pre-NDA meeting with the...
Financing from new and existing investors to advance two European-approved antibiotics for the U.S. market Pivmecillinam Pre-NDA meeting with the...
MONTREAL, QC / ACCESSWIRE / February 4, 2021 / Sunshine Biopharma Inc. (OTC PINK:SBFM), a pharmaceutical company focused on the...
Live Conference Call and Webcast at 4:30 PM ET ENGLEWOOD, CO / ACCESSWIRE / February 4, 2021 / Aytu BioScience,...
MUNICH/MARTINSRIED, GERMANY / ACCESSWIRE / February 4, 2021 / Secarna Pharmaceuticals GmbH & Co. KG ("Secarna"), a biopharmaceutical company focusing...
KATY, TX / ACCESSWIRE / February 4, 2021 / Neutra Corp. (OTC PINK:NTRR) ("Neutra" or "the Company") has decided to...
TÜBINGEN, GERMANY and BOSTON, MA / ACCESSWIRE / February 4, 2021 / CureVac N.V. (NASDAQ:CVAC) ("CureVac" or the "Company"), a...
Access to industry-leading genomic database and real-world evidence designed to optimize trial design, site selection, clinical trial matching and translational...
CV8102 recommended dose identified; expansion trial to confirm safety, tolerability, and efficacy Trial expansion focuses on advanced melanoma, an indication of...
CAMBRIDGE, Mass., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Biogen Inc. (“Biogen”) (Nasdaq: BIIB) today announced the commencement of an offer...
At least 1 in 3 Health Care Professionals (HCPs) are not satisfied with their channel experience Source: The Healthcare CX...
ST. LOUIS, Feb. 04, 2021 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the...
Efixii App Gains Health Canada Cannabis-Consultation Feature for $600 Million MarketVANCOUVER, British Columbia, Feb. 04, 2021 (GLOBE NEWSWIRE) -- Global...
Active Biotech AB (publ) (NASDAQ STOCKHOLM: ACTI) today announced it has reached a manufacturing agreement with Famar Health Care Services...
NOVATO, Calif., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development...
CAMBRIDGE, Mass., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Biogen Inc. (“Biogen”) (Nasdaq: BIIB) today announced the commencement of a private...
3 out of 4 intubated patients were discharged after treatment2 out of 4 patients were extubated within 24 hours of...
TEL AVIV, Israel, Feb. 04, 2021 (GLOBE NEWSWIRE) -- InspireMD, Inc. ("InspireMD") (NYSE:NSPR), a medical device company focused on the...
Company to Participate in Two Q&A Sessions, Including a Joint Discussion with Zai LabSAN DIEGO, Feb. 04, 2021 (GLOBE NEWSWIRE)...
Study Presented At the Society for Critical Care Medicine (SCCM) 50th Congress NEW YORK, Feb. 04, 2021 (GLOBE NEWSWIRE) --...
Loughborough, England, Feb. 04, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology...